Actively Recruiting

Phase 1
Phase 2
Age: 21Years - 70Years
All Genders
ID06814522

Psilocybin-Assisted Therapy for Physician Well-Being and Burnout: Feasibility, Safety, Clinical Effectiveness and Biomarkers of Response

Led by University of California, San Diego · Updated on 2026-01-20

10

Participants Needed

1

Research Sites

4 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Physician burnout is a growing concern linked to poor mental health outcomes, with physicians experiencing higher rates than the general population. This research aims to evaluate the feasibility, safety, and initial effectiveness of Psilocybin-Assisted Therapy (PAT) to reduce burnout symptoms in University of California, San Diego (UCSD) physicians. The study also seeks to identify brain activity changes related to response to this therapy. Participants will receive a single dose of 25 mg of psilocybin combined with psychological support therapy. The open-label trial includes preparatory therapy sessions before the psilocybin dose, followed by post-treatment integration sessions. The therapy aims to produce improvements in psychological areas affected by burnout. During the study, participants will undergo assessments including the Stanford Professional Fulfillment Index (PFI) to measure burnout symptoms from enrollment through a 12-week follow-up. Researchers will monitor safety and feasibility throughout the trial, with no masking or placebo control. Total participation duration covers the initial therapy through the follow-up period to observe lasting effects and changes in wellbeing.

CONDITIONS

Brief Title

Psilocybin-Assisted Therapy for Physician Well-Being and Burnout

Who Can Participate

Age: 21Years - 70Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • UCSD faculty physician aged 21 to 70 years
  • Meets criteria for physician burnout
  • Experiencing burnout symptoms for more than 6 months
  • Able to complete all required study visits
  • Not previously diagnosed with serious mental illness such as schizophrenia, bipolar disorder, or severe depression
  • Not currently taking psychotropic medications or medications linked to serotonin syndrome such as SSRIs, SNRIs, dextromethorphan, linezolid, tramadol, or meperidine
Not Eligible

You will not qualify if you...

  • Previous inpatient psychiatric hospitalization(s)
  • Diagnosed with psychotic disorders, bipolar spectrum disorder, or severe personality disorders
  • Elevated suicide risk
  • First-degree family history of psychosis or bipolar disorder
  • Prior exposure to psilocybin or other psychedelics within the last 10 years
  • Currently pregnant, nursing, planning pregnancy, or sexually active without effective contraception in last 3 months
  • Planning to donate sperm within 3 months after the study
  • Known cardiovascular diseases or clinically significant arrhythmias
  • History of seizure disorder
  • Use of recreational illicit drugs
  • Clinically concerning results from vital signs, ECG, physical exam, or lab tests during screening
  • Any other significant illness posing risk to participant

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Run-in Period

Duration - Variable period before treatment

Participants attend preparatory therapy sessions before receiving the study treatment.

Several preparatory therapy visits

Treatment

Duration - Single treatment day

Participants receive a single dose of psilocybin combined with psychedelic-assisted therapy to address physician burnout.

1 treatment visit (in-person)

Follow-up

Duration - Up to 12 weeks after treatment

Participants attend visits for post-treatment integration and assessment of well-being and safety outcomes.

Multiple follow-up visits over 12 weeks

Trial Site Locations

Total: 1 location

1

UC San Diego

San Diego, California, United States, 92037

Actively Recruiting

Loading map...

Research Team

J

Jessie Kim

C

Cory Weissman

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Similar Trials

A Pilot Study of RISE for Nurse Managers Retreat

Burnout

Actively Recruiting

1 location

Enhancing Resilience and Mental Well-Being Through Structure...

Burnout, Healthcare Workers

Actively Recruiting

4 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here